1. WHO. Global tuberculosis report. 2012. World Health Organization. ISBN 9789241564502.
2. Zumla A, George A, Sharma V, Herbert N, Baroness Masham of Ilton. WHO's 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet. 2013; 382(9907): 1765-7. doi: 10.1016/S0140-6736(13)62078-4. [
DOI:10.1016/S0140-6736(13)62078-4]
3. Png E, Alisjahbana B, Sahiratmadja E, Marzuki S, Nelwan R, Adnan I, et al. Polymorphisms in SP110 are not associated with pulmonary tuberculosis in Indonesians. Infect Genet Evol. 2012; 12(6): 1319-23. doi: 10.1016/j.meegid.2012.04.006. [
DOI:10.1016/j.meegid.2012.04.006]
4. Qu HQ, Fisher-Hoch SP, McCormick JB. Knowledge gaining by human genetic studies on tuberculosis susceptibility. J Hum Genet. 2011; 56(3): 177-82. doi: 10.1038/jhg.2010.164. [
DOI:10.1038/jhg.2010.164]
5. Pan H, Yan BS, Rojas M, Shebzukhov YV, Zhou H, Kobzik L, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature. 2005; 434(7034): 767-72. [
DOI:10.1038/nature03419]
6. Bloch DB, Nakajima A, Gulick T, Chiche JD, Orth D, de La Monte SM,et al. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol. 2000; 20: 6138-46.
7. Fox GJ, Sy DN, Nhung NV, Yu B, Ellis MK, Van Hung N, et al. Polymorphisms of SP110 are associated with both pulmonary and extra-pulmonary tuberculosis among the Vietnamese. PloS one. 2014; 9(7): e99496.
8. Tosh K, Campbell SJ, Fielding K, Sillah J, Bah B, Gustafson P, et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci U S A. 2006; 103(27): 10364-10368. doi: 10.1073/pnas.0603340103. [
DOI:10.1073/pnas.0603340103]
9. Abhimanyu, Jha P, Jain A, Arora K, Bose M. Genetic association study Suggests a role for SP110 variants in lymph node tuberculosis but not pulmonary tuberculosis in north Indians. Hum Immunol. 2011; 72(7): 576-80. doi: 10.1016/j.humimm.2011.03.014..
10. Liang L, Zhao YL, Yue J, Liu JF, Han M, Wang H, et al. Association of SP110 gene polymorphisms with susceptibility to tuberculosis in a Chinese population. Infect Genet Evol. 2011; 11(5): 934-9. doi: 10.1016/j.meegid.2011.02.017. [
DOI:10.1016/j.meegid.2011.02.017]
11. Lei X, Zhu H, Zha L, Wang Y. SP110 gene polymorphisms and tuberculosis susceptibility: A systematic review and meta-analysis based on 10624 subjects. Infect Genet Evol. 2012; 12(7): 1473-80. doi: 10.1016/j.meegid.2012.05.011. [
DOI:10.1016/j.meegid.2012.05.011]
12. Nicewonger J, Suck G, Bloch D, Swaminathan S. Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression. J Virol. 2004; 78(17): 9412-22.
13. Regad T, Chelbi-Alix MK. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene. 2001; 20(49): 7274-86. [
DOI:10.1038/sj.onc.1204854]
14. Abhimanyu, Jha P, Jain A, Arora K, Bose M. Genetic association study suggests a role for SP110 variants in lymph node tuberculosis but not pulmonary tuberculosis in north Indians. Hum Immunol. 2011; 72(7): 576-80. doi: 10.1016/j.humimm.2011.03.014. [
DOI:10.1016/j.humimm.2011.03.014]
15. Babb C, Keet EH, van Helden PD, Hoal EG. SP110 polymorphisms are not associated with pulmonary tuberculosis in a South African population. Hum Genet. 2007; 121(3-4): 521-2.
16. Szeszko JS, Healy B, Stevens H, Balabanova Y, Drobniewski F, Todd JA, et al. Resequencing and association analysis of the SP110 gene in adult pulmonary tuberculosis. Hum Genet. 2007; 121(2): 155-60.
17. Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, et al. No associations of human pulmonary tuberculosis with Sp110 variants. J Med Genet. 2006; 43(7): e32.